Stay updated on Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites across multiple states and updated the page revision to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T17:22:00.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now includes related topic links to Multiple myeloma and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-16T12:28:39.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics from the page.
    Difference
    0.1%
    Check dated 2025-12-09T01:36:49.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Publication section now states that PubMed publications are automatically filled from PubMed, and a new Revision: v3.3.2 was added. The previous PubMed-origin description indicating automatic creation by PubMed with an NCT identifier was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:23:52.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the study page. Removed the government funding status notice.
    Difference
    0.3%
    Check dated 2025-11-17T18:43:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The related topics section no longer includes 'Multiple myeloma' and 'MedlinePlus Genetics', removing disease context and related resources from the page.
    Difference
    0.1%
    Check dated 2025-11-10T17:15:17.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.